Document Detail

Effect of sodium valproate on esophageal motility in healthy subjects and patients with gastroesophageal reflux.
MedLine Citation:
PMID:  15223674     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: There is experimental evidence to show that upper gastrointestinal tract motility is influenced by a GABAergic mechanism. Sodium valproate acts as a GABA agonist, and has been proven to affect the human internal anal sphincter. The aim of this study was to evaluate any possible effect of sodium valproate on esophageal motility in healthy subjects and patients with gastroesophageal reflux disease (GERD). METHODS: Ten healthy volunteers (4 M, 6 F; age range: 20-61 years) and 12 patients (4 M, 8 F; age range: 25-70 years) with GERD were included in the study. Standard esophageal manometry and ambulatory 24-h esophageal pH monitoring were performed before and 5 days after oral administration of sodium valproate (400 mg four times per day). Main measurements included a) lower esophageal sphincter (LES) resting pressure and amplitude and duration of peristalsis at 5, 10 and 15 cm proximal to LES, and b) percentage of time with esophageal pH <4 and number of reflux episodes. RESULTS: Sodium valproate (i) significantly increased LES resting pressure in both groups (P<0.05), without affecting either the LES postdeglutition relaxation or any of the parameters of the esophageal peristaltic activity, (ii) significantly reduced the number of reflux episodes at the postprandial period in both healthy subjects (P=0.02) and reflux patients without hiatal hernia (P=0.04) and (iii) the time percentage with esophageal pH <4 at the postprandial period in reflux patients (P=0.01). CONCLUSIONS: Sodium valproate increases normal and reduced tonic activity of the human LES and reduces the number of reflux episodes in health and GERD. This action could be attributed to a central GABAergic mechanism.
G Tzovaras; J Tsiaoussis; E Athanasakis; O Zoras; E Xynos; E Chrysos
Related Documents :
2513614 - Anorectal manometry after ikeda's z-shaped anastomosis in hirschsprung's disease.
6872304 - Direct choledochography and related diagnostic methods. part 2: sphincter of oddi manom...
2806024 - Postanal repair restores anatomy rather than function.
17391244 - Characterization of sensations induced by capsaicin in the upper gastrointestinal tract.
1418834 - The effect of acute and chronic hematocrit changes on cardiovascular hemodynamics in sp...
8831104 - Effects of hypertension on hypercholesterolemia-induced changes in contraction of rabbi...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Scandinavian journal of gastroenterology     Volume:  39     ISSN:  0036-5521     ISO Abbreviation:  Scand. J. Gastroenterol.     Publication Date:  2004 Jun 
Date Detail:
Created Date:  2004-06-29     Completed Date:  2004-11-02     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0060105     Medline TA:  Scand J Gastroenterol     Country:  Norway    
Other Details:
Languages:  eng     Pagination:  521-6     Citation Subset:  IM    
Laboratory of Gastrointestinal Motility, Dept. of General Surgery, University Hospital of Heraklion, Crete, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Esophagus / drug effects*,  physiopathology*
GABA Agents / pharmacology*
Gastroesophageal Reflux / physiopathology*
Hernia, Hiatal / physiopathology
Middle Aged
Monitoring, Ambulatory
Postprandial Period
Valproic Acid / pharmacology*
Reg. No./Substance:
0/GABA Agents; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Delay in gastric emptying in patients with chronic renal failure.
Next Document:  Achalasia: a vagal disease.